Dr. David Arterburn explains reassuring findings about the nation's most widely used anti-obesity drug.
Dr. Gregory Simon says research is needed to see if this new drug for persistent depression will prevent suicides.
With $10 million from NIMH, KPWHRI is leading a multi-site study to ensure safe prescribing of antipsychotic drugs for youth with behavioral disorders.
For over a decade, Dr. Michael Von Korff and others have been working on a strategy to stop the opioid epidemic. Here’s an outline.
A GHRI researcher worries about easy access to prescription meds after seeing for herself how common they are across the border.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.